|
Volumn 96, Issue 3, 2005, Pages 254-256
|
Evaluation of a physiologically-based pharmacokinetic approach for simulating the first-time-in-animal study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIAZEPAM;
ETHENZAMIDE;
NEW DRUG;
PROPRANOLOL;
CONFERENCE PAPER;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
DRUG RESEARCH;
LIPOPHILICITY;
LIVER BLOOD FLOW;
LIVER METABOLISM;
MATHEMATICAL MODEL;
MEAN RESIDENCE TIME;
PARTITION COEFFICIENT;
PHARMACOKINETICS;
PHYSIOLOGY;
PRIORITY JOURNAL;
TISSUE BLOOD FLOW;
ANIMALS;
BENZAMIDES;
DIAZEPAM;
MODELS, BIOLOGICAL;
PHARMACOKINETICS;
PROPRANOLOL;
RATS;
ANIMALIA;
|
EID: 15244355849
PISSN: 17427835
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1742-7843.2005.pto960321.x Document Type: Conference Paper |
Times cited : (7)
|
References (4)
|